Form 4: West Pharmaceutical Services VP & Treasurer Charles Witherspoon Reports Stock Transactions
SEC Form 4 Filing
Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, reports the exercise of stock options and subsequent sale of shares on August 19, 2024.
Summary
- On August 19, 2024, Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, exercised stock options to acquire 529 shares of common stock at a price of $102.51 per share.
- Following the exercise of the options, Mr. Witherspoon sold 529 shares at $300 per share and 500 shares at $300 per share.
- After these transactions, Mr. Witherspoon beneficially owns 1,478.141 shares of West Pharmaceutical Services common stock.
- The stock options were granted on February 19, 2019, and vested in four equal annual installments beginning on February 19, 2020.
- A Power of Attorney was executed on May 15, 2024, authorizing Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli to act on behalf of Charles Witherspoon for Section 16(a) filings.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Positives
- The exercise of stock options and subsequent sale indicates confidence in the company's value, as the shares were sold at a significantly higher price than the exercise price.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies.
- Form 4 filings are standard practice and are comparable across all companies subject to SEC regulations.
- The reported transactions are similar to those of executives at comparable pharmaceutical and healthcare companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, as insider trading activity is often scrutinized by investors.
Key Dates
| Date | Description |
|---|---|
| 2020-02-19 | First vesting date of the stock options. |
| 2024-05-15 | Date of execution of the Power of Attorney. |
| 2024-08-19 | Date of stock option exercise and sale of shares. |
| 2024-08-21 | Date of signature on the Form 4 filing. |
| 2029-02-19 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.